Literature DB >> 24604006

Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.

Johannes C M Schlachetzki1, Franz Marxreiter2, Martin Regensburger3, Anna Kulinich1, Beate Winner4, Jürgen Winkler1.   

Abstract

PURPOSE: Parkinson's disease (PD) is characterized by striatal synaptic deafferentation followed by dopaminergic cell death in the substantia nigra pars compacta. Not only degenerative, but also regenerative, compensatory changes at distant sites of the primary lesion may occur in PD. The aim of the study was to analyze the temporal pattern of axonal and glial responses over a time course of six weeks post-lesioning.
METHODS: For this aim, 6-hydroxydopamine (6-OHDA) was injected unilaterally into the medial forebrain bundle and both lesioned and non-lesioned striata were analyzed.
RESULTS: We detected increased tyrosine hydroxylase (TH) immunoreactivity within the non-lesioned striatum six weeks after injection indicative either of increased TH expression or compensatory neuritic changes. An increased number of microglial cells was present in both lesioned and unlesioned striata. There was no obvious change in microglial phenotype or in pro-inflammatory cytokine gene expression within the striatum without any apparent switch into a pro-inflammatory phenotype. No changes were observed in the number of mature oligodendrocytes.
CONCLUSIONS: This temporal pattern shows, that the non-lesioned striatum undergoes profound changes, involving increased TH expression accompanied by a glial response. A better understanding of this complex interplay of neuronal as well as glial components not only within the lesioned, but also non-lesioned striatum may help to restore local neural circuits in PD.

Entities:  

Keywords:  6-hydroxydopamine; Parkinson's disease; astrocyte; axonal degeneration; microglia; oligodendrocyte

Mesh:

Substances:

Year:  2014        PMID: 24604006     DOI: 10.3233/RNN-130371

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  11 in total

1.  Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.

Authors:  Molly M Rajsombath; Alice Y Nam; Maria Ericsson; Silke Nuber
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

2.  Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.

Authors:  Fillipe Mendes De Araújo; Annyta Fernandes Frota; Lívia Bacelar de Jesus; Ticiane Caribe Macedo; Lorena Cuenca-Bermejo; Consuelo Sanchez-Rodrigo; Kariny Maria Silva Ferreira; Juciele Valéria Ribeiro de Oliveira; Maria de Fatima Dias Costa; Juan Segura-Aguilar; Silvia Lima Costa; Maria Trinidad Herrero; Victor Diógenes Amaral Silva
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

Review 3.  A review: traditional herbs and remedies impacting pathogenesis of Parkinson's disease.

Authors:  Vishavdeep Sharma; Onkar Bedi; Manisha Gupta; Rahul Deshmukh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-08       Impact factor: 3.000

4.  The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias.

Authors:  Vishakh Iyer; Kala Venkiteswaran; Sandip Savaliya; Christopher A Lieu; Erin Handly; Timothy P Gilmour; Allen R Kunselman; Thyagarajan Subramanian
Journal:  Neurobiol Dis       Date:  2021-08-27       Impact factor: 5.996

5.  Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.

Authors:  Robin M Voigt; Zeneng Wang; J Mark Brown; Phillip A Engen; Ankur Naqib; Christopher G Goetz; Deborah A Hall; Leo Verhagen Metman; Maliha Shaikh; Christopher B Forsyth; Ali Keshavarzian
Journal:  Neurobiol Dis       Date:  2022-05-30       Impact factor: 7.046

Review 6.  Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

Authors:  Fillipe M de Araújo; Lorena Cuenca-Bermejo; Emiliano Fernández-Villalba; Silvia L Costa; Victor Diogenes A Silva; Maria Trinidad Herrero
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

7.  Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons.

Authors:  Jessica Giehrl-Schwab; Florian Giesert; Benedict Rauser; Chu Lan Lao; Sina Hembach; Sandrine Lefort; Ignacio L Ibarra; Christina Koupourtidou; Malte Daniel Luecken; Dong-Jiunn Jeffery Truong; Judith Fischer-Sternjak; Giacomo Masserdotti; Nilima Prakash; Jovica Ninkovic; Sabine M Hölter; Daniela M Vogt Weisenhorn; Fabian J Theis; Magdalena Götz; Wolfgang Wurst
Journal:  EMBO Mol Med       Date:  2022-04-04       Impact factor: 14.260

8.  The innate immune system in Parkinson's disease: a novel target promoting endogenous neuroregeneration.

Authors:  Johannes Cm Schlachetzki; Jürgen Winkler
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

9.  Distinct Effects of Chronic Dopaminergic Stimulation on Hippocampal Neurogenesis and Striatal Doublecortin Expression in Adult Mice.

Authors:  Rachele Salvi; Tobias Steigleder; Johannes C M Schlachetzki; Elisabeth Waldmann; Stefan Schwab; Beate Winner; Jürgen Winkler; Zacharias Kohl
Journal:  Front Neurosci       Date:  2016-03-11       Impact factor: 4.677

10.  Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.

Authors:  Silke Nuber; Molly Rajsombath; Georgia Minakaki; Jürgen Winkler; Christian P Müller; Maria Ericsson; Barbara Caldarone; Ulf Dettmer; Dennis J Selkoe
Journal:  Neuron       Date:  2018-10-10       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.